| 000 | 01778 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517121056.0 | ||
| 264 | 0 | _c20170814 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1872-8421 | ||
| 024 | 7 |
_a10.1016/j.jneuroim.2016.08.018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSawmiller, Darrell | |
| 245 | 0 | 0 |
_aDiosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice. _h[electronic resource] |
| 260 |
_bJournal of neuroimmunology _c10 2016 |
||
| 300 |
_a98-106 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 |
_aCerebral Cortex _xdrug effects |
| 650 | 0 | 4 |
_aCognitive Dysfunction _xdrug therapy |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 | _aCricetulus |
| 650 | 0 | 4 |
_aDiosmin _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, 129 Strain |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_atau Proteins _xantagonists & inhibitors |
| 700 | 1 | _aHabib, Ahsan | |
| 700 | 1 | _aLi, Song | |
| 700 | 1 | _aDarlington, Donna | |
| 700 | 1 | _aHou, Huayan | |
| 700 | 1 | _aTian, Jun | |
| 700 | 1 | _aShytle, R Douglas | |
| 700 | 1 | _aSmith, Adam | |
| 700 | 1 | _aGiunta, Brian | |
| 700 | 1 | _aMori, Takashi | |
| 700 | 1 | _aTan, Jun | |
| 773 | 0 |
_tJournal of neuroimmunology _gvol. 299 _gp. 98-106 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jneuroim.2016.08.018 _zAvailable from publisher's website |
| 999 |
_c26502614 _d26502614 |
||